Pay in 4 interest-free payments of $6.17 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Week 17-24: the half-year milestone Week twenty-four was the primary endpoint of the phase 2 trial, and the results at this mark were what made the medical world take notice
This included a tissue specificity test against differentially expressed genes (DEGs) across all 54 GTEx v8 tissues, with significance defined by a Bonferroni-corrected P-value 0.01 were included
Elderly patients (65+ years) or those on multiple medications : risk of drug interactions and muscle mass loss requires careful management
Learn more in our Retatrutide complete guide
US$ 27.55
US$ 23.65
US$ 26.55
US$ 23.14
US$ 21.43
